• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在精心挑选的股静脉深静脉血栓形成患者中,中心静脉成像可能会发现额外的髂股静脉疾病。

In Well-Selected Patients With a Femoral Deep Vein Thrombosis Central Venous Imaging May Identify Additional Iliocaval Disease.

作者信息

Li Chong, Maldonado Thomas S, Jacobowitz Glenn R, Kabnick Lowell S, Barfield Michael, Rockman Caron B, Berland Todd L, Cayne Neal S, Sadek Mikel

机构信息

Division of Vascular Surgery, Department of Surgery, 12297New York University Langone Medical Center, New York, NY, USA.

5638Morristown Medical Center, Morristown, NJ, USA.

出版信息

Vasc Endovascular Surg. 2020 Nov;54(8):681-686. doi: 10.1177/1538574420946569. Epub 2020 Aug 3.

DOI:10.1177/1538574420946569
PMID:32744182
Abstract

OBJECTIVE

Patients who present acutely with a femoral deep vein thrombosis (DVT) diagnosed by ultrasound are often treated with anticoagulation and instructed to follow-up electively. This study sought to assess whether obtaining axial imaging of the central venous system results in the identification of additional iliocaval pathology warranting treatment.

METHODS

This study was a retrospective review of a prospectively maintained registry from November 2014 through April 2017 with follow-up through March 2020. Consecutive patients with a diagnosis of femoral DVT diagnosed by ultrasound were evaluated; those who underwent axial imaging of the iliocaval system (Group A) were compared to those who did not undergo imaging of the central veins (Group B). The primary outcome was the performance of any percutaneous central venous intervention. Secondary outcomes included the extent of DVT identified on duplex and after axial imaging, follow-up duplex patency and persistence of severe symptoms.

RESULTS

Eighty patients presented with an ultrasound diagnosis of a femoral vein DVT. Mean follow-up was 551 ± 502 days. Group A comprised 24 patients (30%) and Group B comprised 56 patients (70%). Baseline demographics did not differ significantly between the 2 groups. After duplex imaging, Group A exhibited an increased prevalence of DVT in the common femoral vein. After central imaging, Group A exhibited an increased prevalence of DVT in the iliocaval veins. The number of patients who underwent invasive treatment differed significantly between the 2 groups, Group A 16/24 (67%) vs. Group B 9/56 (16%), P < 0.0001. The number of patients that demonstrated duplex patency and had persistent symptoms on follow-up did not differ significantly.

CONCLUSIONS

Patients with an ultrasound diagnosis of femoral DVT may have additional iliocaval pathology warranting intervention. Well-selected imaging of the central veins may reveal a more complete picture, potentially altering management.

摘要

目的

对于经超声诊断为急性股深静脉血栓形成(DVT)的患者,通常采用抗凝治疗并指导其进行择期随访。本研究旨在评估对中心静脉系统进行轴向成像是否能发现需要治疗的其他髂股静脉病变。

方法

本研究是一项对2014年11月至2017年4月前瞻性维护的登记册进行的回顾性研究,随访至2020年3月。对经超声诊断为股DVT的连续患者进行评估;将接受髂股静脉系统轴向成像的患者(A组)与未接受中心静脉成像的患者(B组)进行比较。主要结局是任何经皮中心静脉干预的实施情况。次要结局包括在双功超声检查时以及轴向成像后发现的DVT范围、随访时双功超声检查的通畅情况以及严重症状的持续存在情况。

结果

80例患者经超声诊断为股静脉DVT。平均随访时间为551±502天。A组包括24例患者(30%),B组包括56例患者(70%)。两组的基线人口统计学特征无显著差异。双功超声成像后,A组股总静脉DVT的患病率增加。中心成像后,A组髂股静脉DVT的患病率增加。两组接受侵入性治疗的患者数量有显著差异,A组为16/24(67%),B组为9/56(16%),P<0.0001。双功超声检查通畅且随访时有持续症状的患者数量无显著差异。

结论

经超声诊断为股DVT的患者可能存在需要干预的其他髂股静脉病变。对中心静脉进行精心选择的成像可能会揭示更完整的情况,从而可能改变治疗方案。

相似文献

1
In Well-Selected Patients With a Femoral Deep Vein Thrombosis Central Venous Imaging May Identify Additional Iliocaval Disease.在精心挑选的股静脉深静脉血栓形成患者中,中心静脉成像可能会发现额外的髂股静脉疾病。
Vasc Endovascular Surg. 2020 Nov;54(8):681-686. doi: 10.1177/1538574420946569. Epub 2020 Aug 3.
2
Significance of Partial or Complete Thrombosis of the Common and Deep Femoral Vein in Patients With Deep Vein Thrombosis.股总静脉和股深静脉部分或完全血栓形成对深静脉血栓形成患者的意义。
Eur J Vasc Endovasc Surg. 2019 Oct;58(4):570-575. doi: 10.1016/j.ejvs.2019.06.016. Epub 2019 Aug 31.
3
Anticoagulation reduces iliocaval and iliofemoral stent thrombosis in patients with cancer stented for nonthrombotic venous obstruction.抗凝治疗可降低因非血栓性静脉阻塞而置入支架的癌症患者的髂股静脉和髂总静脉支架血栓形成风险。
J Vasc Surg Venous Lymphat Disord. 2021 Jan;9(1):88-94. doi: 10.1016/j.jvsv.2020.08.004. Epub 2020 Aug 10.
4
Diagnostic value of the femoral vein flow pattern for the detection of an iliocaval venous obstruction.股静脉血流模式对检测髂股静脉梗阻的诊断价值。
J Vasc Surg Venous Lymphat Disord. 2016 Jan;4(1):2-8. doi: 10.1016/j.jvsv.2015.08.002. Epub 2015 Nov 6.
5
Analysis of 1,338 Patients with Acute Lower Limb Deep Venous Thrombosis (DVT) Supports the Inadequacy of the Term "Proximal DVT".分析 1338 例急性下肢深静脉血栓形成(DVT)患者的情况表明,“近端 DVT”这一术语并不恰当。
Eur J Vasc Endovasc Surg. 2016 Mar;51(3):415-20. doi: 10.1016/j.ejvs.2015.11.001. Epub 2016 Jan 6.
6
Posterior tibial vein approach to catheter-directed thrombolysis for iliofemoral deep venous thrombosis.经胫后静脉入路导管直接溶栓治疗髂股型深静脉血栓形成。
J Vasc Surg Venous Lymphat Disord. 2019 Sep;7(5):629-634. doi: 10.1016/j.jvsv.2019.01.064. Epub 2019 Jun 21.
7
Thrombosis in unusual sites of the lower extremity veins.下肢静脉不常见部位的血栓形成。
J Vasc Surg. 2008 May;47(5):1022-7. doi: 10.1016/j.jvs.2007.12.044. Epub 2008 Mar 21.
8
Prevalence, risk factors, and evaluation of iliocaval obstruction in advanced chronic venous insufficiency.髂股静脉阻塞在晚期慢性静脉功能不全中的流行情况、危险因素及评估。
J Vasc Surg Venous Lymphat Disord. 2019 May;7(3):441-447. doi: 10.1016/j.jvsv.2018.10.021. Epub 2019 Feb 11.
9
Editor's Choice - Factors Associated with Long-Term Outcome in 191 Patients with Ilio-Femoral DVT Treated With Catheter-Directed Thrombolysis.编辑推荐——191例接受导管直接溶栓治疗的髂股静脉血栓形成患者的长期预后相关因素
Eur J Vasc Endovasc Surg. 2017 Mar;53(3):419-424. doi: 10.1016/j.ejvs.2016.12.023. Epub 2017 Jan 26.
10
Diameters of acute proximal and distal deep venous thrombosis of the lower limbs.下肢急性近端和远端深静脉血栓形成的直径
Int Angiol. 1998 Dec;17(4):260-7.